Catalyst Wire Dossier Catalyst Wire Dossier

CV2CoV

CV2CoV mRNA vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CV2CoV, covering 2024-08-12 to 2024-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants [Phase 1]

See pricing